alpha 5 beta 1 integrin inhibitors (University of Kentucky)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha 5 beta 1 integrin inhibitors (University of Kentucky)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-5/beta-1 inhibitors
TargetsIntegrin alpha-5/beta-1
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Kentucky
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A